The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 02, 2014

Filed:

Jun. 20, 2011
Applicants:

Takahiro Ogawa, Woodland Hills, CA (US);

Akiharu Isowaki, Woodland Hills, CA (US);

Inventors:

Takahiro Ogawa, Woodland Hills, CA (US);

Akiharu Isowaki, Woodland Hills, CA (US);

Assignee:

Senju USA, Inc., Woodland Hills, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 13/02 (2006.01); A61K 31/56 (2006.01); A61K 9/70 (2006.01); A61K 9/00 (2006.01); A61K 31/58 (2006.01); A61K 31/573 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0014 (2013.01); A61K 31/56 (2013.01); A61K 9/7053 (2013.01); A61K 31/58 (2013.01); A61K 9/0048 (2013.01); A61K 31/573 (2013.01);
Abstract

A transdermal drug delivery system comprising a steroid as an active agent, wherein the steroid may be clobetasol propionate, betamethasone dipropionate, amcinonide, or loteprednol etabonate. The transdermal drug delivery system also comprises a pressure-sensitive adhesive layer and a support, wherein the steroid is present in the pressure-sensitive adhesive layer, and wherein the pressure-sensitive adhesive layer is provided on a support. The transdermal drug delivery system may be applied onto the eyelid of a patient in need thereof, in order to treat a disease of the eyelid, such as chalazion, blepharitis or meibomian gland dysfunction.


Find Patent Forward Citations

Loading…